The New Organisation at the Swedish Medical Products Agency
Monday, September 13, 2010
The MPA has during the past year undergone a thorough survey of processes followed by a reorganisation. The new organisation; with partly new units and areas, will be in operation from September 1, 2010.
The purpose of the reorganisation has been to create better conditions for more efficient work processes and improved coordination between different functions at the MPA. One of the main changes is the establishment of four new assessor departments, Efficacy and Safety 1-4, responsible for clinical and preclinical assessments of new applications or variations. These departments are also responsible for continuous follow-ups of the products. The new Pharmacovigilance department is handling adverse events reports, monitoring signals and responsible for pharmacovigilance inspections. The former Regulatory department is divided into one unit for Regulatory administration and one unit for Product information.
Due to the reorganisation many employees have changed offices within the premises. We apologize for any delays or inconvenience that might occur on account of this and the running-in period the new organisation might need. We do our very best to minimise those.